Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
27.41
+0.09 (0.33%)
At close: Mar 19, 2026, 4:00 PM EDT
27.46
+0.05 (0.18%)
After-hours: Mar 19, 2026, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 13 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $28.15, which forecasts a 2.70% increase in the stock price over the next year. The lowest target is $25 and the highest is $35.
Price Target: $28.15 (+2.70%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 7 | 9 | 10 | 8 | 8 |
| Sell | 1 | 0 | 0 | 0 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 9 | 11 | 11 | 11 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | +16.75% | Mar 17, 2026 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades $35 | Hold → Strong Buy | Upgrades | $35 | +27.69% | Mar 2, 2026 |
| RBC Capital | RBC Capital | Sell Initiates $25 | Sell | Initiates | $25 | -8.79% | Feb 25, 2026 |
| Barclays | Barclays | Sell Initiates $25 | Sell | Initiates | $25 | -8.79% | Feb 20, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $27 | Hold | Reiterates | $27 | -1.50% | Feb 4, 2026 |
Financial Forecast
Revenue This Year
61.77B
from 62.58B
Decreased by -1.29%
Revenue Next Year
59.54B
from 61.77B
Decreased by -3.62%
EPS This Year
2.99
from 1.36
Increased by 118.84%
EPS Next Year
2.85
from 2.99
Decreased by -4.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 65.7B | 65.8B | |||
| Avg | 61.8B | 59.5B | |||
| Low | 58.6B | 55.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.0% | 6.5% | |||
| Avg | -1.3% | -3.6% | |||
| Low | -6.4% | -9.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.33 | 3.18 | |||
| Avg | 2.99 | 2.85 | |||
| Low | 2.74 | 2.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 144.0% | 6.4% | |||
| Avg | 118.8% | -4.5% | |||
| Low | 101.1% | -18.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.